Keywords: Lisinopril, multiple sclerosis

Scientists show that BP drug lisinopril could have value in treating multiple sclerosis

Article | 19 August 2009

Turning serendipity into science, researchers at the Stanford University School of Medicine in the USA have found a link, in mice and in human brain tissue, between high blood pressure and multiple sclerosis. Their findings suggest that a safe, inexpensive drug already in wide use for high blood pressure may have therapeutic value in multiple sclerosis, as well.

Commenting on the study, Helen Yates, Multiple Sclerosis Resource Center chief executive said: “This new piece of research could be very exciting news indeed. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in